Home/Filings/4/0001140361-25-000614
4//SEC Filing

ANDREEFF DANE 4

Accession 0001140361-25-000614

CIK 0001610853other

Filed

Jan 7, 7:00 PM ET

Accepted

Jan 8, 4:10 PM ET

Size

5.7 KB

Accession

0001140361-25-000614

Insider Transaction Report

Form 4
Period: 2025-01-06
ANDREEFF DANE
DirectorPresident and CEO10% Owner
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-01-06+279,715279,715 total
    Exercise: $0.73Exp: 2035-01-05Class A Common Stock (279,715 underlying)
Footnotes (1)
  • [F1]Grant to the Reporting Person of a stock option under the Issuer's 2022 Equity Incentive Plan. 50% of the options vested immediately upon grant, and the remaining options vest in a series of twelve (12) successive equal quarterly installments on the last day of each quarter starting on March 31, 2025, subject to the Reporting Person's continued service through each applicable vesting period.

Issuer

HELIUS MEDICAL TECHNOLOGIES, INC.

CIK 0001610853

Entity typeother

Related Parties

1
  • filerCIK 0001201810

Filing Metadata

Form type
4
Filed
Jan 7, 7:00 PM ET
Accepted
Jan 8, 4:10 PM ET
Size
5.7 KB